Importance Of Collaboration Between The Pharmacy Buyer Clinical
Importance Of Collaboration Between The Pharmacy Buyer & Clinical Pharmacist
Chuck Fogle, Pharm D, DVP Brooke L Richards, B. S. , CPh. T DVP Clinical New Business Development Comprehensive Pharmacy Services Corporate Purchasing Analyst Comprehensive Pharmacy Services
Learning Objectives q. Describe the role of a pharmacy buyer in adding drugs to the formulary q. Outline areas in which a buyer and clinical pharmacist can work together for maximum pharmacy savings new
Learning Objectives (continued) q. Identify obstacles to purchasing in which a buyer/clinical pharmacist collaboration would be helpful q. Explain ways to develop a strong collaborative relationship between the buyer and clinical pharmacist
Overview of Buyer Roles q. Purchasing q. Inventory Management q. Cost savings- Purchase Maximization
Overview of Buyer Roles q. Shortages/Recalls q. Returns- including reverse distribution
Clinical Pharmacist Roles q. Evaluate the appropriateness and effectiveness of the patient’s medication regimen q. Design and maintain all medication protocols q. Maintain and update the hospital formulary
Clinical Pharmacist Roles q. Collaborate with the medical staff to seek alternative drug therapies q. Collaborate with multidisciplinary teams to ensure the best patient care possible
Hospital Formulary- Buyer’s Role A. Attend Pharmacy and Therapeutics meetings B. Assist with needed documentation/research C. A & B D. No role at this time
Hospital Formulary q. Pharmacy & Therapeutics Committee q. Potential Cost Savings- Buyer
Hospital Formulary q. Safety/efficacy- Clinical Pharmacist q. Streamlining products to reduce duplication of therapeutic class
Formulary Additions q. Buyer reviews cost and potential savings of new formulary items q. Potential contract implications
Formulary Additions q. Clinical Pharmacist review safety, efficacy & clinical use q. Reimbursement review
Pharmacy Savings Image Link: http: //problog. weddingwire. com/index. php/business-ideas/tips-on-how-to-save-when-to-spend-money/
New Generics & Biosimilar Medications q. Inflectra® –Biosimilar to Remicade® q. Nitroprusside/Nitropress® q. Daptomycin/Cubicin® q. Nitroglycerin/Nitrostat®
Drug Delivery Systems
Polling Questions q. How many of you forecast the budget for the upcoming year? q. Do you factor in hyperinflated drugs? q. Do you strategize with your clinical pharmacist?
Hyperinflated Medications q. Vasostrict® q. Isuprel® q. Bloxiverz® q. Ephedrine®
Hyperinflated Medications q. Alternatives- generics, biosimilars q. Clinical initiatives q. Usage restrictions
Hyperinflated Medications q. ASHP Foundation Pharmacy Forecast q. National trends in prescription drug expenditures and projections for 2017 q. GPO Forecast
External Compounding q. Potential cost savings comparison q. Vetting of potential compounding companies
Inventory Management q. Quantities to keep on hand- setting min/max par levels q. Review high cost/low use items- consignment?
Obstacles in Purchasing Image Link: http: //www. gq. com/gallery/signs-youre-too-stressed-at-work-and-how-to-fix-that#3
Average Inpatient Drug Spending per Admission Has Increased Substantially Since 2013 $1, 200 +38. 7% $1, 000 $800 $600 $400 $200 $0 FY 2013 FY 2014 FY 2015 Source: AHA-FAH Drug Survey; 2012 -2014 AHA Annual Survey www. aha. org/content/16/aha-fah-rx-report. pdf
Shortages- AJHP Impact survey Results: Ø 353 Respondents Ø 27% Response Rate Ø Pharmacists & Technicians v. Physicians and Nurses Ø Time spent managing shortages / Institution Size Ø Annual Labor Costs: $216 million
Shortages q. Propofol q. Emergency syringes
Drug Recalls q. Docusate liquid q. Epi-pen
Building a Collaborative Relationship Image Link: http: //www. quotemaster. org/community+working+together#&gid=1&pid=18
Building a Collaborative Relationship q. Keep lines of communication open q. Have weekly 1 on 1 meetings q. Share information in a timely manner
Questions? Image link: https: //allthingslearning. wordpress. com/category/guest-bloggers/page/2/
- Slides: 30